2021
Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis
PAZDERNIK, Michal, Helena BEDANOVA, Zhi CHEN, Josef KAUTZNER, Vojtech MELENOVSKY et. al.Základní údaje
Originální název
Donor specific anti-HLA antibodies and cardiac allograft vasculopathy: A prospective study using highly automated 3-D optical coherence tomography analysis
Autoři
PAZDERNIK, Michal (203 Česká republika, garant), Helena BEDANOVA (203 Česká republika), Zhi CHEN, Josef KAUTZNER (203 Česká republika), Vojtech MELENOVSKY (203 Česká republika), Ivan MALEK (203 Česká republika), Antonij SLAVCEV, Michaela BARTONOVA (203 Česká republika), Vladimir KARMAZIN (203 Česká republika), Tomas ECKHARDT (203 Česká republika), Ales TOMASEK (203 Česká republika), Eva OZÁBALOVÁ (203 Česká republika, domácí), Tomas KOVARNIK (203 Česká republika), Peter WOHLFAHRT (203 Česká republika) a Milan SONKA (203 Česká republika)
Vydání
Transplant Immunology, Amsterdam, ELSEVIER, 2021, 0966-3274
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30213 Transplantation
Stát vydavatele
Nizozemské království
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.032
Kód RIV
RIV/00216224:14110/21:00122148
Organizační jednotka
Lékařská fakulta
UT WoS
000633033800006
Klíčová slova anglicky
Cardiac allograft vasculopathy; Donor specific antibodies; Heart transplant; Intimal thickness
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 24. 8. 2021 08:58, Mgr. Tereza Miškechová
Anotace
V originále
Introduction: Recent studies suggested potential positive correlations between HLA-specific antibodies and development of cardiac allograft vasculopathy (CAV). Methods: This prospective two-center study investigated early progression of CAV by coronary optical coherence tomography in 1 month and 12 months after heart transplantation (HTx) in 104 patients. Detection and characterization of donor specific (DSA) and MHC class-I polypeptide-related sequence A (MICA) antibodies were performed before, 1, 6 and 12 months after transplantation. Results: During the first post-HTx year, we observed a significant reduction in the mean coronary luminal area (P < .001), and progression in mean intimal thickness (IT) (P < .001). DSA and anti-MICA occurred in 17% of all patients, but no significant relationship was observed between presence of DSA/anti-MICA and IT progression within 12 months after HTx. In contrast, we observed significant association between presence of DSA (p=0.031), de-novo DSA (p=0.031), HLA Class II DSA (p=0.017) and media thickness (MT) progression. Conclusion: Results of our study did not identify a direct association between presence of DSA/anti-MICA and intimal thickness progression in an early period after HTx. However, we found significant relationships between DSA and media thickness progression that may identify a newly recognized immune-pathological aspect of CAV.